AppYea Enters Commercial Phase with First Deliveries of AppySleep to Customers in the U.S.

GAN YAVNE, ISRAEL / ACCESSWIRE / January 10, 2024 / AppYea, Inc. (OTCQB:APYP), developer of an innovative and accurate wearable monitoring solution to treat sleep apnea and snoring, today announced it has formally entered its commercial phase with the first shipments of AppySleep to customers in the U.S. AppySleep is designed to treat snoring issues through behavior modification.